近視進行抑制点眼薬：マイオピン®（低濃度アトロピン）取扱い中
2022.03.11
近視進行抑制点眼薬：マイオピン®（低濃度アトロピン）0.01%と0.025%を取扱っておりますので、院長・スタッフまでお問合せ下さい。
詳しくはこちら↓
http://www.myopine.jp/
Osamu Hieda, et al. the ATOM-J. Study Group
Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study. Japanese Journal of Ophthalmology volume 65, pages 315–325 2021
https://pubmed.ncbi.nlm.nih.gov/33586090/
https://link.springer.com/article/10.1007/s10384-021-00822-y
2022.03.11
詳しくはこちら↓
http://www.myopine.jp/
Osamu Hieda, et al. the ATOM-J. Study Group
Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study. Japanese Journal of Ophthalmology volume 65, pages 315–325 2021
https://pubmed.ncbi.nlm.nih.gov/33586090/
https://link.springer.com/article/10.1007/s10384-021-00822-y